Stocks TelegraphStocks Telegraph
Stock Ideas

ALXO Stock Performance and Key Statistics

NASDAQ : ALXO

ALX Oncology

$1.88
0.19+11.24%
At Close 4:00 PM
58.13
BESG ScoreESG Rating

stock performance chart

ALXO Fundamental Analysis

Based on recent data, ALX Oncology Holdings Inc. (ALXO) shows an Average True Range (ATR) of 0.25 and an Enterprise Value of 808.26M. Its average trading volume over the past 3 months is 1M, indicating liquidity. These fundamental metrics provide insight into ALXO's underlying financial health and market activity.

ATR0.25
Enterprise Value808.26M
Avg Vol (3 Months)1M
Avg Vol (10 Days)732.86K

ALXO Technical Analysis Indicators

ALX Oncology Holdings Inc. (ALXO) technical indicators as of May 5, 2026: the SMA 20 is 6.23%, SMA 50 at 39.36%, and SMA 200 at 98.51%. The RSI 14 value is 60.18, suggesting its current momentum. These technical analysis signals help assess ALXO's price trends and potential future movements.

SMA 206.23%
SMA 5039.36%
SMA 20098.51%
RSI 1460.18

ALXO Stock Performance Overview

ALX Oncology Holdings Inc. (ALXO) stock performance overview as of May 5, 2026: The 52-week high is $2.66 (currently -11.65% below), and the 52-week low is $0.404 (currently 481.68% above). Over the past year, ALXO's performance is -19.02%, compared to the S&P 500's 16.14% change.

52-Week High2.66
52-Week High Chg-11.65%
52-Week Low0.404
52-Week Low Chg+481.68%
S&P 500 52-Week Chg16.14%

ALX Oncology Holdings Inc. (ALXO) Historical Stock Performance

According to market data, ALX Oncology Holdings Inc. (ALXO) stock's recent performance metrics show that over the last month, ALXO is -8.97%, with a Year-to-Date (YTD) performance of 16.81%. Over the past year, the stock has seen a -19.02% change. These figures summarize ALXO's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High1.912.052.662.662.662.66
Low1.551.551.361.050.4041.07
Performance-8.33%-8.97%-12.00%+175.00%-19.02%+16.81%

Industry Analysis and Valuation

According to current financial data, ALXO stock's P/E (TTM) ratio is -1.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ALXO, including P/S (N/A), P/B (3.98), and P/FCF (-1.22), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationALXOSector MedianIndustry AvgS&P 500
P/E (TTM)-1.02-1.22-5.1232.59
P/S (TTM)N/A3.69464.325.98
P/B (TTM)3.980.28293.84.61
P/FCF (TTM)-1.22254.43-445.4931.99

Frequently Asked Questions

How is ALXO price-to-earnings ratio currently?
ALXO has a current P/E ratio of -1.02
How are ALXO's price-to-sale and price-to-book ratios?
The ALXO stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 3.98.
Is ALX Oncology Holdings Inc.'s price-to-cashflow ratio high or low?
ALXO's price-to-free-cashflow (P/FCF) ratio is -1.22, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for ALXO?
Based on ALXO's recent bid, its distance from 20 days simple moving average is 6.23%. It is 39.36% apart from 50 days simple moving average, and it is 98.51% apart from 200 days simple moving average.
What is the 52-week price range for ALXO?
The 52-week high for ALXO is $2.66 which is -11.65% away from the current price level whereas the distance of that from the 52-week low of $0.40 stands at 481.68%.
An overview of ALXO's stock performance: how did it fare?
The performance of ALXO stock was not encouraging with most of its significant price indicators in green. ALX Oncology Holdings Inc.(NASDAQ: ALXO) shares have moved upward +11.24% or $0.19 in the latest trading session and have gained 16.81% year-to-date (YTD). The stock has lost nearly -19.02% over the past year. After moving -12% over the trailing 3-month period, the stock is 175% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -8.33% a week and -8.97% a month.
What is ALXO's 14-day relative strength index (RSI)?
The current 14-day RSI for ALXO stock is 60.18. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For ALXO, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, ALX Oncology Holdings Inc. (ALXO) has a 14-day ATR of 0.25.
What is ALXO's current enterprise value?
After closing at $1.69 with 54.23M of its shares outstanding, the current enterprise value of ALXO is roughly 808.26M.
Over the past year, how has the stock price of ALXO changed?
ALX Oncology Holdings Inc. (NASDAQ: ALXO) is down -19.02% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 16.14%. ALXO stock price is also up 16.81% on its value in year-to-date trading.
What is the average trading volume for ALXO shares?
The number outstanding shares of ALXO is 54.23M, and of these 69.63% shares are freely available for trading. On average, ALXO stock has traded 732.86K shares per day for the past 10 days. A total of 705.24K shares changed hands during the last trading session with the average session volume of 975.59K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph